Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GCGR | P47871 | 19/20 | 0.57 |
| ▸ | ADCY6 | O43306 | 6/20 | 0.57 |
| ▸ | ADCY3 | O60266 | 6/20 | 0.57 |
| ▸ | ADCY9 | O60503 | 6/20 | 0.57 |
| ▸ | ADCY5 | O95622 | 6/20 | 0.57 |
| ▸ | ADCY8 | P40145 | 6/20 | 0.57 |
| ▸ | ADCY7 | P51828 | 6/20 | 0.57 |
| ▸ | ADCY2 | Q08462 | 6/20 | 0.57 |
| ▸ | ADCY1 | Q08828 | 6/20 | 0.57 |
| ▸ | ADCY4 | Q8NFM4 | 6/20 | 0.57 |
| ▸ | GIPR | P48546 | 6/20 | 0.55 |
| ▸ | GLP1R | P43220 | 1/20 | 0.55 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2665025 | 0.94 | GCGR (0.56) | GCGRADCY6ADCY3ADCY9ADCY5 | |
| SCHEMBL2665202 | 0.91 | GCGR (0.57) | GCGRADCY6ADCY3ADCY9ADCY5 | |
| SCHEMBL2665191 | 0.91 | GCGR (0.59) | GCGRADCY6ADCY3ADCY9ADCY5 | |
| SCHEMBL2664990 | 0.91 | GCGR (0.67) | GCGRADCY6ADCY3ADCY9ADCY5 | |
| SCHEMBL2665108 | 0.90 | GCGR (0.67) | GCGRADCY6ADCY3ADCY9ADCY5 | |
| SCHEMBL2664975 | 0.90 | GCGR (0.58) | GCGRADCY6ADCY3ADCY9ADCY5 | |
| SCHEMBL2665199 | 0.88 | GCGR (0.64) | GCGRADCY6ADCY3ADCY9ADCY5 | |
| SCHEMBL9071466 | 0.88 | GCGR (0.62) | GCGRADCY6ADCY3ADCY9ADCY5 | |
| SCHEMBL2665006 | 0.88 | GCGR (0.64) | GCGRADCY6ADCY3ADCY9ADCY5 | |
| SCHEMBL2665205 | 0.87 | GCGR (0.58) | GCGRADCY6ADCY3ADCY9ADCY5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2003048109-A1 | NOVEL GLUCAGON ANTAGONISTS | NOVO NORDISK A/S (DK) | 2003-06-12 | — | — | WO | disclosed |